Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
39.15
-0.30 (-0.76%)
At close: Jul 2, 2024, 4:00 PM
38.69
-0.46 (-1.17%)
After-hours: Jul 2, 2024, 7:30 PM EDT

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $770.01M in the twelve months ending March 31, 2024, down -3.11% year-over-year. Revenue in the quarter ending March 31, 2024 was $191.67M with 13.16% year-over-year growth. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, a decrease of -6.68%.

Revenue (ttm)
$770.01M
Revenue Growth
-3.11%
P/S Ratio
3.28
Revenue / Employee
$320,837
Employees
2,400
Market Cap
2.53B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018183.87M76.27M70.88%
Dec 31, 2017107.60M23.35M27.72%
Dec 31, 201684.25M11.40M15.65%
Dec 31, 201572.85M23.13M46.51%
Dec 31, 201449.72M20.72M71.41%
Dec 31, 201329.01M26.53M1,072.00%
Dec 31, 20122.48M--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
agilon health 4.78B
Progyny 1.11B
ACADIA Pharmaceuticals 813.81M
ADMA Biologics 283.18M
MorphoSys AG 264.75M
Rhythm Pharmaceuticals 91.93M
Agios Pharmaceuticals 29.40M
Revenue Rankings